Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis-Reference-Cited by-同舟云学术

Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis

Published:2014-06 Issue: Volume:162 Page:20-25
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Stewart Thomas D.,Hatch Ainslie,Largay Kimberly,Sheehan John J.,Marler Sabrina V.,Berman Robert M.,Nelson J. Craig

Funder

Bristol-Myers Squibb

Otsuka America Pharmaceutical, Inc.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference20 articles.

1. Practice Guideline for the Treatment of Patients with Major Depressive Disorder,2010

2. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;J. Clin. Psychiatry,2007

3. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectr.,2009

4. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine;Bose;Clin. Drug Investig.,2012

5. Diagnosis and definition of treatment-resistant depression;Fava;Biol. Psychiatry,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model);S.S. Korsakov Journal of Neurology and Psychiatry;2024

2. Use of the Third-Generation Atypical Antipsychotic Aripiprazole (Zylaxera®) for Treatment of Depressive States in Schizophrenia: Efficacy and Safety Study;Psikhiatriya;2023-06-19

3. The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study;Clinical Psychopharmacology and Neuroscience;2019-11-20

4. Major Depressive Disorder and Bipolar Disorder: Differentiating Features and Contemporary Treatment Approaches;Understanding Depression;2017-10-25

5. Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine;Neuropsychiatric Disease and Treatment;2017-09